ADVFN - Advanced Financial Network.
HOME» NYSE » D » DVA Stock Price » DVA Stock News

Davita Share News

 Davita Inc. Stock Price
DVA Stock Price
 Davita Inc. Stock Chart
DVA Stock Chart
 Davita Inc. Stock News
DVA Stock News
 Davita Inc. Company Information
DVA Company Information
 Davita Inc. Stock Trades
DVA Stock Trades

DaVita Agrees to $55 Million Settlement

DaVita Inc. (DVA) agreed to pay roughly $55 million in a settlement of a lawsuit filed by an individual in 2002 related to the anemia drug Epogen. The dialysis-service provider said the agreement, which also includes the payment of attorneys fees, contains no findings of wrongdoing or admission of liability by the company. "DaVita and its affiliated physicians did nothing wrong and stand by their anemia management practices," the company said. In a previous SEC filing, the company identified the individual as Ivey Woodard and said it was served with a complaint under the qui tam provisions of the federal False Claims Act. DaVita also said the government investigated allegations raised by the individual; however, it chose not to file claims against DaVita. DaVita's shares closed at $97.62 on Monday and were inactive premarket. The stock is up 29% year-to-date. Write to Saabira Chaudhuri at

Stock News for Davita (DVA)
10/02/201519:55:22Statement of Changes in Beneficial Ownership (4)
10/02/201519:54:54Statement of Changes in Beneficial Ownership (4)
10/02/201519:54:25Statement of Changes in Beneficial Ownership (4)
10/02/201519:54:02Statement of Changes in Beneficial Ownership (4)
10/02/201519:53:32Statement of Changes in Beneficial Ownership (4)
10/02/201519:53:07Statement of Changes in Beneficial Ownership (4)
10/02/201519:52:36Statement of Changes in Beneficial Ownership (4)
10/02/201519:52:10Statement of Changes in Beneficial Ownership (4)
09/30/201505:07:00DaVita to Establish Operations in Brazil
09/29/201505:56:0030 Years of Clinical Research Milestones
09/22/201509:10:00Healthcare Sector Equities Coverage -- HCA Holdings, Tenet Healthcare...
09/21/201509:35:00Washington's Everett Clinic to Join DaVita HealthCare Partners
09/21/201506:07:00Atul Mathur Named Executive Vice President of DaVita Global Operations
09/21/201506:07:00Atul Mathur Named Executive Vice President of DaVita Global Operations
09/15/201506:11:00600 Cyclists Take Part in Ninth Annual Tour DaVita®
09/14/201506:11:0010th Anniversary of Nephrology Nurses Week Recognized in September
09/02/201505:03:00Lauren Edgington Named CFO of HealthCare Partners' Florida Market
08/31/201505:03:00DaVita to Form Kidney Care Specialty Hospital Chain in China
08/26/201514:49:00Dinesh Kumar Named Senior VP of Clinical Transformation at DaVita...
08/24/201507:50:00DaVita Healthcare to Buy Renal Ventures for $415 Million

Davita and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations